BlackRock Health Sciences Trust II (BMEZ) is a publicly traded company in the Financial Services sector, operating within the Asset Management industry. The company is headquartered in New York City, NY, United States. The current CEO is Xiang Liu.
BMEZ has IPO date of 2020-01-29, listed on the NYSE, a market capitalization of $1.5B.
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
